Is using an open-reservoir cardiopulmonary bypass circuit after 6 days on standby safe?

OBJECTIVES To investigate the sterility and biocompatibility of a stored open-reservoir cardiopulmonary bypass circuit maintained on standby. METHODS A total of four cardiopulmonary bypass circuits were assembled, primed and left to recirculate. One unit was placed in a positive-pressure operating room and the other three were placed in the intensive care unit. The primed solutions, which employed Ringer's acetate, hydroxyethylated starch and hydrate steroid, were sampled after 0, 24, 48, 72, 96, 120 and 144 h in all cardiopulmonary bypass circuits to measure the bacteria count, endotoxin count and chemical substances within the primed solution. Chemical substances were detected by assessing the following: the total organic carbon by the combustion oxidation infrared spectrometry, and molecular weight spread by gel permeation chromatography. The environments were left unattended and were uncovered during the storage period to mimic the clinical scenario. RESULTS There were no bacteria in any of the primed solutions, and only very minute concentrations of endotoxins were detected, both in the operating room and in the intensive care unit. The total organic carbon concentration was slightly more concentrated in the 144-h samples when compared with that in the 0-h samples. However, the molecular weight spread of the 0-h sample was identical to that in the 144-h sample. DISCUSSION With regard to the presence of bacteria and endotoxins, we noted that the hardshell reservoirs in the cardiopulmonary bypass circuit were effectively sealed and not invaded by bacteria. With regard to the presence of chemical substances, we noted that an increase in total organic carbon concentration was caused by bedewing, and that there was no release of chemical substances such as a polymer-coating agent, or other molecular materials in the primed solution. CONCLUSIONS There was no contamination or release of chemical substances in 6-day old cardiopulmonary bypass circuits maintained on standby, confirming that they are safe to use in terms of sterility and biocompatibility.

[1]  H. Izutani,et al.  Features of an alternative hemodialysis method using a hemoconcentrator during cardiopulmonary bypass surgeries , 2015, Perfusion.

[2]  S. Takanashi,et al.  Biocompatibility of cardiopulmonary bypass circuit with new polymer Senko E-Ternal CoatingTM , 2015, Perfusion.

[3]  R. Serrato Lipopolysaccharides in diazotrophic bacteria , 2014, Front. Cell. Infect. Microbiol..

[4]  H. Izutani,et al.  Prospects for using a hemoconcentrator as an alternative hemodialysis method in cardiopulmonary bypass surgeries , 2014, Perfusion.

[5]  C. Clerté,et al.  Influence of Anaerobiosis and Low Temperature on Bacillus cereus Growth, Metabolism, and Membrane Properties , 2012, Applied and Environmental Microbiology.

[6]  D. Berdajs,et al.  The new advanced membrane gas exchanger. , 2011, Interactive cardiovascular and thoracic surgery.

[7]  T. Gourlay,et al.  The effect of priming solutions and storage time on plasticizer migration in different PVC tubing types--implications for wet storage of ECMO systems. , 2009, The journal of extra-corporeal technology.

[8]  M. Prayson,et al.  Time-dependent contamination of opened sterile operating-room trays. , 2008, The Journal of bone and joint surgery. American volume.

[9]  L. V. von Segesser,et al.  Comparing oxygen transfer performance between three membrane oxygenators: effect of temperature changes during cardiopulmonary bypass. , 2007, Artificial organs.

[10]  T. Hartung,et al.  In vitro pyrogen test for toxic or immunomodulatory drugs. , 2006, Journal of immunological methods.

[11]  Michael V Sefton,et al.  Endotoxin: the uninvited guest. , 2005, Biomaterials.

[12]  D. S. Lawson,et al.  Evaluation of a preprimed microporous hollow-fiber membrane for rapid response neonatal extracorporeal membrane oxygenation , 2005, Perfusion.

[13]  C. Tuleu,et al.  A wet-primed extracorporeal membrane oxygenation circuit with hollow-fiber membrane oxygenator maintains adequate function for use during cardiopulmonary resuscitation after 2 weeks on standby* , 2005, Critical care medicine.

[14]  C. Tuleu,et al.  Plasticizer di(2-ethylhexyl)phthalate (DEHP) release in wet-primed extracorporeal membrane oxygenation (ECMO) circuits. , 2005, International journal of pharmaceutics.

[15]  S. Suehiro,et al.  A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy. , 2004, The Annals of thoracic surgery.

[16]  A. Stammers,et al.  The effects of preprimed oxygenators on gas transfer efficiency. , 2003, The journal of extra-corporeal technology.

[17]  S. Tada,et al.  Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass. , 2003, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[18]  D. Mitchell,et al.  Extracorporeal circuit sterility after 168 hours. , 1997, The journal of extra-corporeal technology.

[19]  M. Walsh-sukys,et al.  Impact of prolonged saline solution prime exposure on integrity of extracorporeal membrane oxygenation circuits. , 1997, Journal of perinatology : official journal of the California Perinatal Association.

[20]  T. C. Beaman,et al.  Chemical Composition and Ultrastructure of Native and Reaggregated Membranes from Protoplasts of Bacillus cereus , 1974, Journal of bacteriology.

[21]  J. Manďák,et al.  How long can the previously assembled cardiopulmonary bypass circuit stay sterile? , 1998, Acta medica.